WallStreetZenWallStreetZen

NASDAQ: GDTC
Cytomed Therapeutics Ltd Stock Ownership - Who owns Cytomed Therapeutics?

OverviewEarningsRevenueDividendOwnership

Insider buying vs selling

Have Cytomed Therapeutics Ltd insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Chee Kong ChooDirector2026-07-20100,000$1.50
$150.00kBuy
Chee Kong ChooDirector2026-07-20100,000$1.50
$150.00kBuy
Chee Kong ChooDirector2026-07-14100,000$1.50
$150.00kBuy
Chee Kong ChooDirector2026-07-14100,000$1.50
$150.00kBuy
Chee Kong ChooDirector2026-05-13112,000$1.15
$128.80kBuy

1 of 1

GDTC insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when GDTC insiders and whales buy or sell their stock.

GDTC Shareholders

What type of owners hold Cytomed Therapeutics Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Glorious Finance Ltd39.34%4,653,604$4.01MInsider
Chee Kong Choo27.99%3,310,261$2.85MInsider
Shu Wang7.47%883,858$761.00kInsider
Jieming Zeng4.98%589,239$507.33kInsider
Lucas Tien Wee Luk0.78%92,563$79.70kInsider
Yoong Ying Tan0.22%25,781$22.20kInsider
Yvonne Goh0.22%25,781$22.20kInsider
Keng Kiat Toh0.03%4,000$3.44kInsider
Chak Hua Yew0.02%2,469$2.13kInsider
Axiom10.00%7$6.03Institution

1 of 2

GDTC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GDTC0.00%81.06%Net BuyingNet Buying
AZTR0.03%32.39%
APRE0.00%100.00%Net Buying
XBIO0.00%100.00%
SNTI0.02%82.16%
View Top Biotech Stocks

Cytomed Therapeutics Stock Ownership FAQ

Who owns Cytomed Therapeutics?

Cytomed Therapeutics (NASDAQ: GDTC) is owned by 0.00% institutional shareholders, 81.06% Cytomed Therapeutics insiders, and 18.94% retail investors. Glorious Finance Ltd is the largest individual Cytomed Therapeutics shareholder, owning 4.65M shares representing 39.34% of the company. Glorious Finance Ltd's Cytomed Therapeutics shares are currently valued at $4.05M.

If you're new to stock investing, here's how to buy Cytomed Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.